secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immuneering Corp (IMRX)
CIK:        0001790340
Form:       8-K
Filed at:   2025-08-25T23:59:59+00:00
Accession:  0001104659-25-081995
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immuneering raises $25M in private placement at $3.95/unit, warrants at $5.50
-----------------------------------------------------------------------------

- $25M gross proceeds from 6.33M shares (or pre-funded warrants) and 2.85M warrants at $5.50.
- Combined purchase price of $3.95 per unit, representing a ~15% premium over Aug. 20 close.
- Proceeds to support clinical development of atebimetinib in first-line pancreatic cancer.
- Closing expected on or about August 26, 2025; registration rights agreement filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1790340/000110465925081995/0001104659-25-081995-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1790340/000110465925081995/tm2524079d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-081995

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer